Given that Smad4 deletion in tumor cells promoted the sensitivity to host immune response, we speculated that Smad4 deletion might enhance the tumor cells’ immunogenicity, which promoted immune recognition of tumor cells. The gene discussed is SMAD4; the disease is neoplasm.